Vitaligo Repigmentation
One of the most exciting developments in dermatology in the past year has been a topical medication, a cream, that effectively repigments the skin, says Studio City, CA dermatologist Gene Rubinstein, MD. “Opzelura, the brand name of the medication whose active ingredient is tapinarof, was recently approved by the FDA to treat vitiligo,” he explains. “It works by reducing the activity of certain immune cells that attack the pigment-producing cells in the skin. This leads to an increase in the production of melanin, which is responsible for the color of our skin. In clinical trials, it has demonstrated significant improvement in the repigmentation of skin. It is a promising option for those struggling with vitiligo, and we have seen good results, especially in patients with new vitiligo and facial depigmentation.”